NCT05513469View on ClinicalTrials.gov

Biomarker Identification of Radionuclide Therapy-induced Radiation Responses

NAUnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

October 1, 2024

Study Completion Date

October 1, 2024

Conditions
Neuroendocrine Tumors
Interventions
DRUG

Lutathera

regulair PRRT of 4 cycles with 7.4GBq

Trial Locations (1)

3015 GD

RECRUITING

Erasmus MC, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER